MELBOURNE, Australia, Sept. 15, 2021 /PRNewswire/ -- DEP® cabazitaxel is a proprietary nanoparticle version of leading prostate cancer drug cabazitaxel (Jevtana®), which had global sales of US$536 million in 2020. Starpharma's DEP® cabazitaxel is a water soluble, polysorbate-80 free formulation, without requirement for...
When you’re looking to sell a house, there are a number of different things you need to take into account before you can do that. One of the main ...
Colour Psychology Bhavani Lee an Associate Creative Director at Vista Australia has shared her insights and expertise on the psychology behind co...
From Corporate Merchandise to Hand Sanitiser Entrepreneur Dorry Kordahi has pivoted his business in the midst of the global pandemic to produce an...
A business plan with financial forecasts is an essential tool for entrepreneurs as it provides a roadmap for the future of their business and helps ...
Taking cues from the warm winter colours of tobacco and caramel, and combining them with the strength of navy and the embracing lightness of whites ...
Property in Berwick Waters has become an extremely sought-after commodity over the last few years, and it's not hard to see why. The perfect weath...